178 related articles for article (PubMed ID: 8748050)
1. Encephalopathy during amitriptyline therapy: are neuroleptic malignant syndrome and serotonin syndrome spectrum disorders?
Miyaoka H; Kamijima K
Int Clin Psychopharmacol; 1995 Nov; 10(4):265-7. PubMed ID: 8748050
[TBL] [Abstract][Full Text] [Related]
2. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
Khaldi S; Kornreich C; Choubani Z; Gourevitch R
Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
[TBL] [Abstract][Full Text] [Related]
3. Neuroleptic malignant syndrome without the use of neuroleptics.
Heyland D; Sauvé M
CMAJ; 1991 Oct; 145(7):817-9. PubMed ID: 1913410
[No Abstract] [Full Text] [Related]
4. Neuroleptic malignant syndrome and lithium carbonate.
Fava S; Galizia AC
J Psychiatry Neurosci; 1995 Jul; 20(4):305-6. PubMed ID: 7647084
[TBL] [Abstract][Full Text] [Related]
5. Trimipramine-induced neuroleptic malignant syndrome after transient psychogenic polydipsia in one patient.
Langlow JR; Alarcon RD
J Clin Psychiatry; 1989 Apr; 50(4):144-5. PubMed ID: 2925603
[TBL] [Abstract][Full Text] [Related]
6. Serotonin syndrome overlapping with neuroleptic malignant syndrome: A case report and approaches for differentially diagnosing the two syndromes.
Nisijima K
Asian J Psychiatr; 2015 Dec; 18():100-1. PubMed ID: 26506919
[TBL] [Abstract][Full Text] [Related]
7. [A patient with Parkinson's disease complicated by hypothyroidism who developed malignant syndrome after discontinuation of etizolam].
Kawajiri M; Ohyagi Y; Furuya H; Araki T; Inoue N; Esaki S; Yamada T; Kira J
Rinsho Shinkeigaku; 2002 Feb; 42(2):136-9. PubMed ID: 12424963
[TBL] [Abstract][Full Text] [Related]
8. [Monoamine imbalance of the central nervous system in a case of Shy-Drager syndrome with recurrent attacks of a neuroleptic malignant syndrome].
Ueda M; Hamamoto M; Otsubo K; Miyazaki T; Terashi A
Rinsho Shinkeigaku; 1996 May; 36(5):696-8. PubMed ID: 8905993
[TBL] [Abstract][Full Text] [Related]
9. Toxic serotonin syndrome or neuroleptic malignant syndrome?
Fink M
Pharmacopsychiatry; 1996 Jul; 29(4):159-61. PubMed ID: 8858716
[TBL] [Abstract][Full Text] [Related]
10. [Etiologic mechanism of neuroleptic malignant syndrome--hypothesis of dopamine-serotonin imbalance].
Yamawaki N
Seishin Shinkeigaku Zasshi; 1988; 90(10):869-76. PubMed ID: 3251270
[No Abstract] [Full Text] [Related]
11. [A case of impending neuroleptic malignant syndrome associated with Shy-Drager syndrome].
Kumagai R; Harada T; Kurokawa K; Okazaki M; Egi N; Shimote K; Nakamura S
No To Shinkei; 1998 Aug; 50(8):745-9. PubMed ID: 9757468
[TBL] [Abstract][Full Text] [Related]
12. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
Ozen ME; Yumru M; Savas HA; Cansel N; Herken H
World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349
[TBL] [Abstract][Full Text] [Related]
13. Ziprasidone- and lithium-induced neuroleptic malignant syndrome.
Borovicka MC; Bond LC; Gaughan KM
Ann Pharmacother; 2006 Jan; 40(1):139-42. PubMed ID: 16352776
[TBL] [Abstract][Full Text] [Related]
14. [A study of neuroleptic malignant syndrome in the presenium and senium].
Suzuki I; Honma H; Watanabe N; Matsubara S; Koyama T
Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353
[TBL] [Abstract][Full Text] [Related]
15. Neuroleptic malignant syndrome from central nervous system insult: 4 cases and a novel treatment strategy. Clinical article.
Wait SD; Ponce FA; Killory BD; Wallace D; Rekate HL
J Neurosurg Pediatr; 2009 Sep; 4(3):217-21. PubMed ID: 19772404
[TBL] [Abstract][Full Text] [Related]
16. [Torecan-induced neuroleptic malignant syndrome].
Bulvik S; Shimoni Z; Kaplan CL
Harefuah; 1990 May; 118(10):576-8. PubMed ID: 2358219
[TBL] [Abstract][Full Text] [Related]
17. Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five cases.
Nisijima K; Ishiguro T
J ECT; 1999 Jun; 15(2):158-63. PubMed ID: 10378156
[TBL] [Abstract][Full Text] [Related]
18. [Neuroleptic malignant syndrome, syndrome malin].
Takahashi A; Todoroki J; Murasaki M
Nihon Rinsho; 1996 Mar; 54(3):839-44. PubMed ID: 8904246
[TBL] [Abstract][Full Text] [Related]
19. Neuroleptic malignant syndrome and serotonin syndrome.
Nisijima K; Shioda K; Iwamura T
Prog Brain Res; 2007; 162():81-104. PubMed ID: 17645916
[TBL] [Abstract][Full Text] [Related]
20. Diagnosing subtypes of neuroleptic malignant syndrome: an introduction to the Lee-Carroll Scale.
Carroll BT; Lee JW; Graham KT; Thalassinos A; Thomas C; Kirkhart R
Ann Clin Psychiatry; 2008; 20(1):47-8. PubMed ID: 18297586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
